A citation-based method for searching scientific literature

Sharon E Frey, Michael Houghton, Stephen Coates, Sergio Abrignani, David Chien, Domenico Rosa, Piero Pileri, Ranjit Ray, Adrian M Di Bisceglie, Paola Rinella, Heather Hill, Mark C Wolff, Viola Schultze, Jang H Han, Bruce Scharschmidt, Robert B Belshe. Vaccine 2010
Times Cited: 168







List of co-cited articles
1219 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans.
John Lok Man Law, Chao Chen, Jason Wong, Darren Hockman, Deanna M Santer, Sharon E Frey, Robert B Belshe, Takaji Wakita, Jens Bukh, Christopher T Jones,[...]. PLoS One 2013
127
58

Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus.
Erick Giang, Marcus Dorner, Jannick C Prentoe, Marlène Dreux, Matthew J Evans, Jens Bukh, Charles M Rice, Alexander Ploss, Dennis R Burton, Mansun Law. Proc Natl Acad Sci U S A 2012
256
46

Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses.
William O Osburn, Anna E Snider, Brittany L Wells, Rachel Latanich, Justin R Bailey, David L Thomas, Andrea L Cox, Stuart C Ray. Hepatology 2014
177
45

Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge.
Mansun Law, Toshiaki Maruyama, Jamie Lewis, Erick Giang, Alexander W Tarr, Zania Stamataki, Pablo Gastaminza, Francis V Chisari, Ian M Jones, Robert I Fox,[...]. Nat Med 2008
462
44

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C.
Jan M Pestka, Mirjam B Zeisel, Edith Bläser, Peter Schürmann, Birke Bartosch, Francois-Loïc Cosset, Arvind H Patel, Helga Meisel, Jens Baumert, Sergei Viazov,[...]. Proc Natl Acad Sci U S A 2007
409
44

A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.
Leo Swadling, Stefania Capone, Richard D Antrobus, Anthony Brown, Rachel Richardson, Evan W Newell, John Halliday, Christabel Kelly, Dan Bowen, Joannah Fergusson,[...]. Sci Transl Med 2014
243
42

Vaccination of chimpanzees against infection by the hepatitis C virus.
Q L Choo, G Kuo, R Ralston, A Weiner, D Chien, G Van Nest, J Han, K Berger, K Thudium, C Kuo. Proc Natl Acad Sci U S A 1994
483
40

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.
Eleanor Barnes, Antonella Folgori, Stefania Capone, Leo Swadling, Stephen Aston, Ayako Kurioka, Joel Meyer, Rachel Huddart, Kira Smith, Rachel Townsend,[...]. Sci Transl Med 2012
312
36

Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection.
William O Osburn, Brian E Fisher, Kimberly A Dowd, Giselle Urban, Lin Liu, Stuart C Ray, David L Thomas, Andrea L Cox. Gastroenterology 2010
261
34

HCV persistence and immune evasion in the absence of memory T cell help.
Arash Grakoui, Naglaa H Shoukry, David J Woollard, Jin-Hwan Han, Holly L Hanson, John Ghrayeb, Krishna K Murthy, Charles M Rice, Christopher M Walker. Science 2003
624
32

Hepatitis C virus E2 envelope glycoprotein core structure.
Leopold Kong, Erick Giang, Travis Nieusma, Rameshwar U Kadam, Kristin E Cogburn, Yuanzi Hua, Xiaoping Dai, Robyn L Stanfield, Dennis R Burton, Andrew B Ward,[...]. Science 2013
285
32


Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource.
Donald B Smith, Jens Bukh, Carla Kuiken, A Scott Muerhoff, Charles M Rice, Jack T Stapleton, Peter Simmonds. Hepatology 2014
876
27

Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees.
Trevor J Morin, Teresa J Broering, Brett A Leav, Barbra M Blair, Kirk J Rowley, Elisabeth N Boucher, Yang Wang, Peter S Cheslock, Michael Knauber, David B Olsen,[...]. PLoS Pathog 2012
123
27

Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection.
Naglaa H Shoukry, Arash Grakoui, Michael Houghton, David Y Chien, John Ghrayeb, Keith A Reimann, Christopher M Walker. J Exp Med 2003
474
27

A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.
Antonella Folgori, Stefania Capone, Lionello Ruggeri, Annalisa Meola, Elisabetta Sporeno, Bruno Bruni Ercole, Monica Pezzanera, Rosalba Tafi, Mirko Arcuri, Elena Fattori,[...]. Nat Med 2006
233
25

Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus.
Jean-Christophe Meunier, Judith M Gottwein, Michael Houghton, Rodney S Russell, Suzanne U Emerson, Jens Bukh, Robert H Purcell. J Infect Dis 2011
79
31

Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus.
Kimberly A Dowd, Dale M Netski, Xiao-Hong Wang, Andrea L Cox, Stuart C Ray. Gastroenterology 2009
175
24

Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees.
Gamal A Elmowalid, Ming Qiao, Sook-Hyang Jeong, Brian B Borg, Thomas F Baumert, Ronda K Sapp, Zongyi Hu, Krishna Murthy, T Jake Liang. Proc Natl Acad Sci U S A 2007
126
24

Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2.
Abdul Ghafoor Khan, Jillian Whidby, Matthew T Miller, Hannah Scarborough, Alexandra V Zatorski, Alicja Cygan, Aryn A Price, Samantha A Yost, Caitlin D Bohannon, Joshy Jacob,[...]. Nature 2014
198
24

Approaches, Progress, and Challenges to Hepatitis C Vaccine Development.
Justin R Bailey, Eleanor Barnes, Andrea L Cox. Gastroenterology 2019
107
24

Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization.
Jason Alexander Ji-Xhin Wong, Rakesh Bhat, Darren Hockman, Michael Logan, Chao Chen, Aviad Levin, Sharon E Frey, Robert B Belshe, D Lorne Tyrrell, John Lok Man Law,[...]. J Virol 2014
54
42

Broadly neutralizing antibodies abrogate established hepatitis C virus infection.
Ype P de Jong, Marcus Dorner, Michiel C Mommersteeg, Jing W Xiao, Alejandro B Balazs, Justin B Robbins, Benjamin Y Winer, Sherif Gerges, Kevin Vega, Rachael N Labitt,[...]. Sci Transl Med 2014
162
22

The core domain of hepatitis C virus glycoprotein E2 generates potent cross-neutralizing antibodies in guinea pigs.
Patricia T Vietheer, Irene Boo, Jun Gu, Kathleen McCaffrey, Stirling Edwards, Catherine Owczarek, Matthew P Hardy, Louis Fabri, Rob J Center, Pantelis Poumbourios,[...]. Hepatology 2017
48
45

The past, present and future of neutralizing antibodies for hepatitis C virus.
Jonathan K Ball, Alexander W Tarr, Jane A McKeating. Antiviral Res 2014
93
22

Neutralizing antibodies induced by cell culture-derived hepatitis C virus protect against infection in mice.
Daisuke Akazawa, Masaki Moriyama, Hiroshi Yokokawa, Noriaki Omi, Noriyuki Watanabe, Tomoko Date, Kenichi Morikawa, Hideki Aizaki, Koji Ishii, Takanobu Kato,[...]. Gastroenterology 2013
56
37

Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate.
Zhen-yong Keck, Jinming Xia, Yong Wang, Wenyan Wang, Thomas Krey, Jannick Prentoe, Thomas Carlsen, Angela Ying-Jian Li, Arvind H Patel, Stanley M Lemon,[...]. PLoS Pathog 2012
168
21

Characterization of antibodies induced by vaccination with hepatitis C virus envelope glycoproteins.
Ranjit Ray, Keith Meyer, Arup Banerjee, Arnab Basu, Stephen Coates, Sergio Abrignani, Michael Houghton, Sharon E Frey, Robert B Belshe. J Infect Dis 2010
75
28

Neutralizing antibody response during acute and chronic hepatitis C virus infection.
C Logvinoff, M E Major, D Oldach, S Heyward, A Talal, P Balfe, S M Feinstone, H Alter, C M Rice, J A McKeating. Proc Natl Acad Sci U S A 2004
323
19

Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG.
Michael Logan, John Law, Jason Alexander Ji-Xhin Wong, Darren Hockman, Amir Landi, Chao Chen, Kevin Crawford, Juthika Kundu, Lesley Baldwin, Janelle Johnson,[...]. J Virol 2016
28
67

Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection.
Kimberly Page, Michael T Melia, Rebecca T Veenhuis, Matthew Winter, Kimberly E Rousseau, Guido Massaccesi, William O Osburn, Michael Forman, Elaine Thomas, Karla Thornton,[...]. N Engl J Med 2021
50
38


Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein.
Ania Owsianka, Alexander W Tarr, Vicky S Juttla, Dimitri Lavillette, Birke Bartosch, François-Loïc Cosset, Jonathan K Ball, Arvind H Patel. J Virol 2005
227
18

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.
Elisa Scarselli, Helenia Ansuini, Raffaele Cerino, Rosa Maria Roccasecca, Stefano Acali, Gessica Filocamo, Cinzia Traboni, Alfredo Nicosia, Riccardo Cortese, Alessandra Vitelli. EMBO J 2002
879
18

Binding of hepatitis C virus to CD81.
P Pileri, Y Uematsu, S Campagnoli, G Galli, F Falugi, R Petracca, A J Weiner, M Houghton, D Rosa, G Grandi,[...]. Science 1998
18

Cooperativity in virus neutralization by human monoclonal antibodies to two adjacent regions located at the amino terminus of hepatitis C virus E2 glycoprotein.
Zhenyong Keck, Wenyan Wang, Yong Wang, Patrick Lau, Thomas H R Carlsen, Jannick Prentoe, Jinming Xia, Arvind H Patel, Jens Bukh, Steven K H Foung. J Virol 2013
96
18

Global distribution and prevalence of hepatitis C virus genotypes.
Jane P Messina, Isla Humphreys, Abraham Flaxman, Anthony Brown, Graham S Cooke, Oliver G Pybus, Eleanor Barnes. Hepatology 2015
978
18

Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence.
Julian Schulze Zur Wiesch, Donatella Ciuffreda, Lia Lewis-Ximenez, Victoria Kasprowicz, Brian E Nolan, Hendrik Streeck, Jasneet Aneja, Laura L Reyor, Todd M Allen, Ansgar W Lohse,[...]. J Exp Med 2012
161
18

A prime-boost strategy using virus-like particles pseudotyped for HCV proteins triggers broadly neutralizing antibodies in macaques.
Pierre Garrone, Anne-Catherine Fluckiger, Philippe E Mangeot, Emmanuel Gauthier, Pia Dupeyrot-Lacas, Jimmy Mancip, Arnaud Cangialosi, Isaure Du Chéné, Roger LeGrand, Isabelle Mangeot,[...]. Sci Transl Med 2011
105
17

Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus.
Teresa J Broering, Kerry A Garrity, Naomi K Boatright, Susan E Sloan, Frantisek Sandor, William D Thomas, Gyongyi Szabo, Robert W Finberg, Donna M Ambrosino, Gregory J Babcock. J Virol 2009
139
17

Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo.
Thomas von Hahn, Joo Chun Yoon, Harvey Alter, Charles M Rice, Barbara Rehermann, Peter Balfe, Jane A McKeating. Gastroenterology 2007
298
17

Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX vaccine: a phase I study in healthy volunteers.
Debbie Drane, Eugene Maraskovsky, Rebecca Gibson, Sue Mitchell, Megan Barnden, Alan Moskwa, David Shaw, Barbara Gervase, Stephen Coates, Michael Houghton,[...]. Hum Vaccin 2009
78
21

Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine.
Elodie Beaumont, Romuald Patient, Christophe Hourioux, Isabelle Dimier-Poisson, Philippe Roingeard. Hepatology 2013
48
35

Hepatitis C virus vaccine candidates inducing protective neutralizing antibodies.
Catherine Fauvelle, Che C Colpitts, Zhen-Yong Keck, Brian G Pierce, Steven K H Foung, Thomas F Baumert. Expert Rev Vaccines 2016
46
36

Affinity maturation of a broadly neutralizing human monoclonal antibody that prevents acute hepatitis C virus infection in mice.
Zhen-Yong Keck, Yong Wang, Patrick Lau, Garry Lund, Sneha Rangarajan, Catherine Fauvelle, Grant C Liao, Frederick W Holtsberg, Kelly L Warfield, M Javad Aman,[...]. Hepatology 2016
49
34

Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance.
Justin R Bailey, Andrew I Flyak, Valerie J Cohen, Hui Li, Lisa N Wasilewski, Anna E Snider, Shuyi Wang, Gerald H Learn, Nurgun Kose, Leah Loerinc,[...]. JCI Insight 2017
82
20

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.
Takaji Wakita, Thomas Pietschmann, Takanobu Kato, Tomoko Date, Michiko Miyamoto, Zijiang Zhao, Krishna Murthy, Anja Habermann, Hans-Georg Kräusslich, Masashi Mizokami,[...]. Nat Med 2005
16

Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion.
Sukanya Raghuraman, Heiyoung Park, William O Osburn, Emily Winkelstein, Brian R Edlin, Barbara Rehermann. J Infect Dis 2012
117
16

Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization.
Jannick Prentoe, Tanja B Jensen, Philip Meuleman, Stéphanie B N Serre, Troels K H Scheel, Geert Leroux-Roels, Judith M Gottwein, Jens Bukh. J Virol 2011
118
16

Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies.
Zania Stamataki, Stephen Coates, Matthew J Evans, Mark Wininger, Kevin Crawford, Christine Dong, Yiu-Lian Fong, David Chien, Sergio Abrignani, Peter Balfe,[...]. Vaccine 2007
70
22


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.